financial results

AAC Technologies reported strong 2025 interim results, with revenue up 18.4% to RMB 13.32 billion and net profit surging 63.1% to RMB 876 million. The company projects continued growth, driven by demand for thermal management solutions, MEMS microphones, and advancements in its Wafer Level Glass (WLG) lens technology, with shipments expected to exceed 10 million units this year. The acoustics business saw modest revenue growth while the optics division excelled. AAC is also expanding its presence in the automotive sector, securing key design wins and seeing revenue increase by 14.2%.

TrustBIX Inc. (TSXV: TBIX) reported a widened net loss of $255,984 in Q3 2025, compared to a $9,773 loss in Q3 2024, with revenue declining 40.8% to $324,545. Despite revenue challenges, operating expenses improved over nine months, and cash from operating activities increased by 70.5% in Q3. The Alberta Food Security team secured new indoor farming technology orders, with initial deliveries commencing in June 2025, though manufacturing delays are being addressed.

Else Nutrition (TSX: BABY) reported Q1 2025 results with steady revenue of $2.1 million CAD. Operating expenses decreased by 48%, leading to a gross profit increase to $0.5 million CAD and a gross margin of 25%. The company is focusing on cost reduction by moving powder formula manufacturing to Europe, strengthening retail partnerships, and advancing plant-based infant nutrition through regulatory channels. A conference call to discuss the results is scheduled for today at 10:00 AM Eastern Time.

Oconee Federal Financial Corp. (OFED) reported a net income of $4.2 million ($0.73 per diluted share) for fiscal year 2025, down from $6.3 million the previous year. Total assets grew slightly to $668.2 million, with the loan portfolio expanding to $478.7 million. The company maintained its $0.10 per share dividend for the 55th consecutive quarter. CEO Curtis T. Evatt cited the Mutual Savings Bank acquisition and interest rate environment as factors boosting net interest margin. The board declared a $0.10 dividend payable August 21, 2025.

ATRenew Inc. (NYSE: RERE) reported strong Q2 2025 results, with net revenues up 32.2% YoY to RMB 4,991.5 million ($696.8 million). The company achieved profitability with income from operations of RMB 91.1 million ($12.7 million), a significant improvement from the previous year. The number of transacted consumer products grew to 10.3 million. ATRenew anticipates Q3 2025 revenue between RMB 5,050.0 million and RMB 5,150.0 million. A new $50 million share repurchase program was authorized.

BingEx (FLX) reported Q2 2025 revenue of RMB1,024.6 million (US$143.0 million), down from RMB1,176.7 million YoY, due to market competition. However, gross profit margin improved to 12.0% from 10.8%. Net income was RMB53.5 million (US$7.5 million). The company fulfilled 64.8 million orders and repurchased approximately 0.8 million ADSs for US$2.6 million under its share repurchase program. They maintain a strong cash position of RMB827.8 million (US$115.6 million).

HCW Biologics (HCWB) reported mixed Q2 2025 results. A $5M equity raise helped shore up finances and debt was extinguished. However, revenue plummeted to $6,550, and the Wugen License Agreement was suspended. R&D spending decreased while G&A expenses increased. Despite reducing its net loss, the company expresses doubt about its ability to continue without additional funding. They are seeking new licensing deals and clinical trials are planned. HCWB regained Nasdaq compliance but remains under Panel Monitor.

SINOPEC Engineering Group (SENGF) announced strong H1 2025 results, with revenue up 10.1% to RMB 31.559 billion and net profit increasing 4.8% to RMB 1.388 billion. New contract values reached a record RMB 71.158 billion, a 42.1% YoY increase, driven by an 82.7% surge in overseas contracts. Key projects include the Maoming Refinery Transformation and Hassi Messaoud Refinery in Algeria. An interim dividend of RMB 0.160 per share was declared. The company maintained an industry-leading AA ESG rating.

Viomi Technology (VIOT) anticipates H1 2025 revenue exceeding RMB 1.4 billion, a 70%+ year-over-year increase. This growth is fueled by strong sales of household water purification equipment, supported by Chinese government subsidies and increasing consumer demand for cleaner water. CEO Xiaoping Chen cites disciplined execution and rising health consciousness as drivers for long-term growth. However, the results are preliminary and unaudited, and reliance on subsidies presents a potential risk.

Amaze Holdings (AMZE) reported a significant 1134% revenue increase to $0.87M in Q2 2025, fueled by 200M storefront visits and 12M active creators. GMV reached $3.77M with a $50 AOV. Despite growth, the company experienced a $5.0M net loss due to increased SG&A expenses. Management anticipates sequential revenue growth in Q3/Q4 2025 and potential short-term profitability. Strategic partnerships and new platform features aim to solidify long-term success.